Grufity logo
Grufity logo
TOI

TOI - The Oncology Institute, Inc. Stock Price, Fair Value and News

$5.11-0.07 (-1.35%)
Market Closed as of 16 Jun 2026, 04:00 pm ET

67/100

TOI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

67/100

TOI

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

TOI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TOI Price Action

Last 7 days

2.2%

Last 30 days

30.2%

Last 90 days

44.3%

Trailing 12 Months

109.7%

TOI RSI Chart

TOI Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

TOI Valuation

Market Cap

510.9M

Price/Earnings (Trailing)

-11.74

Price/Sales (Trailing)

0.94

EV/EBITDA

-14.41

Price/Free Cashflow

-19.86

TOI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

TOI Fundamentals

TOI Revenue

Revenue (TTM)

545.8M

Rev. Growth (Yr)

41.22%

Rev. Growth (Qtr)

3.86%

TOI Earnings

Earnings (TTM)

-43.5M

Earnings Growth (Yr)

87.28%

Earnings Growth (Qtr)

66.81%

TOI Profitability

EBT Margin

-8.00%

Return on Equity

267.2%

Return on Assets

-25.87%

Free Cashflow Yield

-5.04%

TOI Investor Care

Shares Dilution (1Y)

12.42%

Diluted EPS (TTM)

-0.35

TOI Alerts

  • 1 major insider buys and 2 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
2026545.8M---
2025403.2M424.4M461.0M502.7M
2024342.7M361.1M378.9M393.4M
2023273.5M292.8M309.9M324.2M
2022209.6M220.7M233.4M252.5M
2021191.4M195.3M199.1M203.0M
2020---187.5M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About The Oncology Institute, Inc.

TOI
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates in three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient blood product transfusions, and patient support services. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
 WEBSITEtheoncologyinstitute.com
 SECTORHealthcare
 INDUSTRYMedical Care Facilities
 EMPLOYEES750

The Oncology Institute, Inc. Frequently Asked Questions

TOI is the stock ticker symbol of The Oncology Institute, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Mon Jun 15 2026, market cap of The Oncology Institute, Inc. is 517.86 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Mon Jun 15 2026, TOI's PE ratio (Price to Earnings) is -11.9 and Price to Sales (PS) ratio is 0.95. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TOI PE ratio will change depending on the future growth rate expectations of investors.